OncoGenex Technologies   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Bothell WA United States (1991)
Status: Acquired by Achieve Life Sciences (2017)

Organization Overview

First Clinical Trial
2002
NCT00034190
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree